Lamictal (Lamotrigine)

Lamotrigine works by inhibiting voltage‑gated sodium channels on neurons, which stabilises neuronal membranes and reduces the release of excitatory neurotransmitters such as glutamate. This dampens neuronal hyper‑excitability, providing seizure control and mood‑stabilising effects.

The appropriate dose of Lamictal is determined individually by a qualified prescriber based on the patient’s condition, age, weight, renal function and any concomitant medications. Dosing regimens are tailored during treatment and should not be altered without medical advice.

The safety of lamotrigine in pregnancy and lactation is not fully established. It should be used only if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss risks and alternatives with their healthcare provider.

To request Lamictal, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will verify trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Lamictal differs from many antiepileptics by primarily targeting sodium channels and reducing glutamate release, offering a broad spectrum of seizure control with a relatively favorable cognitive profile. Compared with older agents such as carbamazepine, it has fewer drug‑interaction concerns but requires careful titration to minimise skin‑reaction risk.

Lamictal should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the tablet container tightly closed, protect it from moisture, heat and direct sunlight to maintain product stability.

Lamictal is taken orally, usually as a tablet, with or without food. The prescriber will advise a gradual titration schedule to reach the therapeutic dose while monitoring for adverse reactions, especially skin rash.

The most serious risks include severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, blood dyscrasias, hepatic failure, and the emergence of suicidal thoughts or behavior. Immediate medical attention is required if any of these symptoms appear.

Lamictal is contraindicated in individuals with a known hypersensitivity to lamotrigine or any of its excipients. Patients with a history of severe skin reactions (e.g., Stevens‑Johnson syndrome) should avoid it, and it should be used with caution in those with significant renal or hepatic impairment.